术前量表预测冠状动脉旁路移植术后全因再入院
该研究利用加州和纽约126,519例患者(推导队列)及佛罗里达和华盛顿94,318例患者(验证队列)的行政数据,开发并验证了一个预测CABG术后30天再入院风险的术前量表。推导队列和验证队列的30天再入院率分别为23%和21%,量表在验证队列中解释了98%的再入院变异。
要点
- CABG术后30天再入院率在推导队列为23%,验证队列为21%。
- 预测因素包括高龄、女性(OR 1.34)、非裔美国人(OR 1.13)、医疗保险及合并症如肾衰竭(OR 1.56)和充血性心力衰竭(OR 2.82)。
- 术前再入院的CABG量表在验证队列中解释了98%的再入院变异。
核心结论
- CABG术后再入院量表能可靠预测患者30天再入院风险,识别高危患者后可实施风险降低策略以减少再入院和医疗支出。
研究设计与样本
- 研究从州住院患者数据库(2006至2011年)提取加州和纽约126,519例患者作为推导队列,佛罗里达和华盛顿94,318例患者作为验证队列,开发并验证预测30天再入院风险的CABG术后再入院量表。
主要发现
- 30天CABG再入院率在推导队列为23%,在验证队列为21%。
- 预测因素包括高龄、女性(OR 1.34)、非裔美国人(OR 1.13)、医疗保险或医疗补助保险,以及合并症包括肾衰竭(OR 1.56)和充血性心力衰竭(OR 2.82),这些因素独立预测再入院率增加(p < 0.01)。
- 再入院量表在验证队列中解释了98%的再入院变异。
关键数值与推荐
- 预测因素包括高龄、女性(OR 1.34)、非裔美国人(OR 1.13)、医疗保险或医疗补助保险、肾衰竭(OR 1.56)和充血性心力衰竭(OR 2.82),均独立预测再入院率增加(p < 0.01)。
临床怎么用
- 作者认为,通过术前识别再入院高危患者,可实施风险降低策略以减少再入院和医疗支出。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery bypass graft (CABG) operations are associated with all-cause readmission rates of approximately 15%. In attempts to reduce readmission rates, the Hospital Readmission Reduction Program expanded to include CABG operations in 2015. The aim of this study was therefore to develop a predictive readmission scale that would identify patients at higher risk of readmission after CABG using commonly available administrative data. METHODS: Data of 126,519 patients from California and New York (derivation cohort) and 94,318 patients from Florida and Washington (validation cohort) were abstracted from the State Inpatient Database (2006 to 2011). The readmission after CABG scale was developed to predict 30-day readmission risk and was validated against a separate cohort. RESULTS: Thirty-day CABG readmission rates were 23% in the derivation cohort and 21% in the validation cohort. Predictive factors included older age, female gender (odds ratio [OR], 1.34), African American ethnicity (OR, 1.13), Medicare or Medicaid insurance, and comorbidities, including renal failure (OR, 1.56) and congestive heart failure (OR, 2.82). These were independently predictive of increased readmission rates (p < 0.01). The readmission scale was then created with these preoperative factors. When applied to the validation cohort, it explained 98% of the readmission variability. CONCLUSIONS: The readmission after CABG scale reliably predicts a patient's 30-day CABG readmission risk. By identifying patients at high-risk for readmission before their procedure, risk reduction strategies can be implemented to reduce readmissions and healthcare expenditures.
引用
- Zywot A, Lau CSM, Glass N, et al. Preoperative Scale to Determine All-Cause Readmission After Coronary Artery Bypass Operations. Ann Thorac Surg. 2017. PMID: 29288658. doi:10.1016/j.athoracsur.2017.11.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。